NEW
Stock Screener with Intrinsic Value
Alnylam Pharmaceuticals, Inc. (ALNY)
Last Price$238.0(1.1%)
Market Cap$30.1B
2.6x
Industry median - 4.4x
5Y Historical average - 3.3x
(91.5x)
Industry median - 1.0x
5Y Historical average - (2.1x)
FCF to Interest
0.1x
Industry median - (28.9x)
5Y Historical average - (5.3x)
4,023.7%
Industry median - 3.9%
5Y Historical average - (4,477.0%)
ALNY Health Rating
Crunching data... Almost there!
ALNY Financial Stability & Strength
Crunching data... Almost there!
Competing with ALNY Financial Health
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
FAQ
What is the Alnylam Pharmaceuticals, Inc. (ALNY) quick ratio?
The Alnylam Pharmaceuticals, Inc. (ALNY) quick ratio is 2.6x, compared to the industry median of 4.4x and the 5-year historical average of 3.3x.
What is the Alnylam Pharmaceuticals, Inc. (ALNY) net debt to Free Cash Flow (FCF) ratio?
The Alnylam Pharmaceuticals, Inc. (ALNY) net debt to FCF ratio is (91.5x), compared to the industry median of 1.0x and the 5-year historical average of ((2.1x)).
What is Alnylam Pharmaceuticals, Inc. (ALNY) Free Cash Flow (FCF) to interest ratio?
Alnylam Pharmaceuticals, Inc. (ALNY) FCF to interest ratio is 0.1x, compared to the industry median of (28.9x) and the 5-year historical average of (5.3x).
What is the Alnylam Pharmaceuticals, Inc. (ALNY) total debt to equity ratio?
The Alnylam Pharmaceuticals, Inc. (ALNY) total debt to equity ratio is 4,023.7%, compared to the industry median of 3.9% and the 5-year historical average of (4,477.0%).